Compound 1373
Identifiers
- Canonical SMILES:
CNC(=O)c1cc(OC)c(O[C@@H](C)C(=O)N2CCN(C[C@H]2C)c2nccc3cnccc23)cn1
- InChi:
InChI=1S/C24H28N6O4/c1-15-14-29(22-18-6-7-26-12-17(18)5-8-27-22)9-10-30(15)24(32)16(2)34-21-13-28-19(23(31)25-3)11-20(21)33-4/h5-8,11-13,15-16H,9-10,14H2,1-4H3,(H,25,31)/t15-,16+/m1/s1
- InChiKey:
ILRZGXUOQBZBAD-CVEARBPZSA-N
External links
![]() 168317985 |
External search
![]() |
![]() |
![]() |
![]() |
![]() |
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
0 | 1 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
CD4 / gp120 | 7.54 | HIV infectious disease | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 464.22 g/mol | |||
HBA | 10 | |||
HBD | 1 | |||
HBA + HBD | 11 | |||
AlogP | 0.89 | |||
TPSA | 109.78 | |||
RB | 6 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 0 | 1 | 0 | 0 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.5882 | Atevirdine | DB12264 | |
0.5000 | Lecozotan | DB12540 | |
0.4950 | Delavirdine | DB00705 | |
0.4721 | USL-311 | DB15265 | |
0.4641 | 4-[[2-[[4-chloro-3-(trifluoromethyl)phenyl]amino]-3H-benzimidazol-5-yl]oxy]-N-methyl-pyridine-2-carboxamide | DB06938 | |
0.4581 | ORM-13070 C-11 | DB15324 | |
0.4528 | Sonidegib | DB09143 | |
0.4500 | Vesnarinone | DB12082 | |
0.4450 | Doxazosin | DB00590 | |
0.4279 | E-6005 | DB12776 | |
0.4244 | Tamatinib | DB07159 | |
0.4229 | CM-4307 | DB15414 | |
0.4229 | Sorafenib | DB00398 | |
0.4221 | Ensartinib | DB14860 | |
0.4191 | X-396 | DB13104 |